Jueyu Zhou

Prof. Jueyu Zhou


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2022 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
YCYi-Hong Chen
Yi-Hong Chen
NXNan-Zhu Xu
Nan-Zhu Xu
CHChang Hong
Chang Hong
WLWen-Qi Li
Wen-Qi Li
YZYi-Qiong Zhang
Yi-Qiong Zhang
JZJueyu Zhou
Jueyu Zhou
Myosin 1b (Myo1b) is an important single-headed membrane-associated motor of class I myosins that participate in many critical physiological and pathological processes. Mounting evidence suggests that the dysregulation of Myo1b expression has been extensively investigated in the development and progression of several tumors. However, the functional mechanism of Myo1b in CRC angiogenesis and autophagy progression remains unclear. Herein, we found that the expression of Myo1b was upregulated in CRC tissues and its high expression was correlated with worse survival. The overexpression of Myo1b promoted the proliferation, migration and invasion of CRC cells. Conversely, silencing of Myo1b suppressed tumor progression both in vitro and in vivo. Further studies indicated that Myo1b inhibited the autophagosome-lysosome fusion and potentiated the VEGF secretion of CRC cells to promote angiogenesis. Mechanistically, Myo1b blocked the autophagic degradation of HIF-1α and then led to the accumulation of HIF-1α, thus enhancing VEGF secretion and then promoting tumor angiogenesis in CRC. Together, our study provided novel insights into the role of Myo1b in CRC progression and revealed that it might be a feasible predictive biomarker and promising therapeutic target for CRC patients.

19 January 2018 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
ZZZhen-Fei Zhang
Zhen-Fei Zhang
HZHan-Rong Zhang
Han-Rong Zhang
QZQing-Yan Zhang
Qing-Yan Zhang
SLShu-Yu Lai
Shu-Yu Lai
YFYu-Zhen Feng
Yu-Zhen Feng
JZJueyu Zhou
Jueyu Zhou
Bladder cancer (BCa) is one of the most common cancers in the urinary system among the world. Previous studies suggested that TMEM40 expression level was significantly associated with clinicopathological parameters including histological grade, clinical stage and pT status of bladder cancer. However, the molecular mechanism of TMEM40 in BCa remains poorly understood. Real-time quantitative RT-PCR (qRT-PCR) and western blot (WB) were used to examine the expression levels of TMEM40 in BCa tissues, paired non-cancer tissues and cell lines. A series of experiments, including CCK-8, wound healing, flow cytometry, transwell and EdU assays were performed to assess the effects of TMEM40 on cell proliferation, cell cycle and apoptosis, migration and invasion. In addition, tumor growth was evaluated in vivo using a xenogenous subcutaneously implant model. All statistical analyses were executed by using the SPSS 20.0 software. All experimental data from three independent experiments were analyzed by Student’s t test and results were expressed as mean ± standard deviation. In this study, we identified the role of TMEM40 in the tumorigenesis of bladder cancer and found that it was upregulated in bladder cancer tissues and cell lines, compared with their normal counterparts. The results demonstrated that effective silence of TMEM40 expression suppressed cell proliferation, blocked G1-to-S cell cycle transition, and inhibited cell migration and invasion in human bladder 5637 and EJ cell lines. Consistently, in vivo data showed that TMEM40 silencing could dramatically decreased tumor growth. Further study revealed that TMEM40 knockdown resulted in accumulation of p53 and p21 protein and decrease of c-MYC and cyclin D1 protein. These data suggest that TMEM40 represents a potential oncogene, which exert a crucial role in the proliferation and apoptosis via the p53 signaling pathway in BCa, thus probably serve as a novel candidate biomarker and a potential therapeutic target for patients with BCa.

1 January 2018 in Journal of Cancer
Verified
Journal Article
Open access
SZSi-Rong Zheng
Si-Rong Zheng
HZHan-Rong Zhang
Han-Rong Zhang
ZZZhen-Fei Zhang
Zhen-Fei Zhang
SLShu-Yu Lai
Shu-Yu Lai
LHLi-Jun Huang
Li-Jun Huang
JZJueyu Zhou
Jueyu Zhou
Cervical cancer is one of the most common cancer in female worldwide. The expression of high-risk human papillomavirus E7 oncogene is necessary for the maintenance of malignant phenotypes and transformation. Accumulating studies of this protein has been explored in cervical cancer, however, there are fewer studies on how E7 expression affects the expression of global circular RNA. CircRNA, a promising biomarker and even therapeutic target, has become a star molecular in research after miRNA and long non-coding RNA. Our aim of this study was to investigate the global circRNA levels modulated by HPV E7 expression and identified the potential consequences for mechanism studies. Here we investigated the expression profiles of circRNAs by transfecting E7 siRNA in Caski cells with high-throughput microarray technology. In total, we identified 526 dysregulated circRNAs with fold change ≥2 or≤0.5, and p< 0.05. Among them, 352 were up-regulated and 174 were down-regulated. In addition, 8 selected circRNAs confirmed using qRT-PCR was in line with the results of microarray analysis. Furthermore, bioinformatic analyses indicated that differently expressed circRNAs might implicate in the mTOR signaling pathway, proline metabolism and glutathione metabolism. In conclusion, this study showed the expression profiles of circRNAs regulated by HPV16 E7 in cervical cancer cells and provides novel insights into the new potential candidates for future mechanism studies.

30 September 2009 in BMB Reports
Verified
Journal Article
Open access
PDF file
JZJueyu Zhou
Jueyu Zhou
WMWen-Li Ma
Wen-Li Ma
SLShuang Liang
Shuang Liang
YZYe Zeng
Ye Zeng
RSRong Shi
Rong Shi
WZWen-Ling Zheng
Wen-Ling Zheng
Cell cycle progression is regulated by both transcriptional and post-transcriptional mechanisms. MicroRNAs (miRNAs) emerge as a new class of small non-coding RNA regulators of cell cycle as recent evidence suggests. It is hypothesized that expression of specific miRNAs oscillates orderly along with cell cycle progression. However, the oscillated expression patterns of many candidate miRNAs have yet to be determined. Here, we describe miRNA expression profiling in double-thymidine synchronized HeLa cells as cell cycle progresses. Twenty-five differentially expressed miRNAs were classified into five groups based on their cell cycle-dependent expression patterns. The cyclic expression of six miRNAs (miR-221, let-7a, miR-21, miR-34a, miR-24, miR-376b) was validated by real-time quantitative RT-PCR (qRT-PCR). These results suggest that specific miRNAs, along with other key factors are required for maintaining and regulating proper cell cycle progression. The study deepens our understanding on cell cycle regulation. [BMB reports 2009; 42(9): 593-598].

1 April 2018 in Gynecologic Oncology
Verified
Journal Article
Closed access
HZHan-Rong Zhang
Han-Rong Zhang
SLShu-Yu Lai
Shu-Yu Lai
LHLi-Jun Huang
Li-Jun Huang
ZZZhen-Fei Zhang
Zhen-Fei Zhang
JLJie Liu
Jie Liu
JZJueyu Zhou
Jueyu Zhou

22 March 2016 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
JZJueyu Zhou
Jueyu Zhou
SZSi-Rong Zheng
Si-Rong Zheng
JLJie Liu
Jie Liu
RSRong Shi
Rong Shi
HYHai-Lang Yu
Hai-Lang Yu
MWMin Wei
Min Wei
MicroRNAs (miRNAs) play pivotal roles in the development of various cancer types, including cervical cancer. In this study, we showed that miR-519d, a miRNA within the chromosome 19 miRNA cluster, was significantly upregulated in cervical cancer tissues, compared with non-tumorous cervical samples. Suppression of miR-519d markedly attenuated the migration and invasion of HeLa and SiHa cervical cancer cells. Additionally, miR-519d inhibited the apoptosis of cervical cancer cells, and the proliferation of cervical cancer cells was also affected following transfection of miR-519d inhibitor. Moreover, we identified Smad7 to be a novel target of miR-519d in cervical cancer cells. MiR-519d matched the 3′-UTR of Smad7 mRNA. Transfection with miR-519d mimics led to apparent downregulation of Smad7 both at the mRNA and protein levels. Luciferase reporter analysis revealed that miR-519d reduced the luciferase activity of Smad7 mRNA 3′-UTR through matching site-dependent manner. And more notably, suppression of Smad7 remarkably restored the migration and invasion of miR-519d-depleted cervical cancer cells. Taken together, these findings implicated that miR-519d promoted the progression and metastasis of cervical cancer through targeting Smad7.